Catalyst
Slingshot members are tracking this event:
Sarepta Therapeutics Announces FDA Will Not Complete the Review of the Eteplirsen New Drug Application By The PDUFA Date
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
SRPT | Community voting in process |
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 25, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Rna-targeted Therapeutics, Pdufa, Eteplirsen, Fda